Alydia Health this week said it has appointed Paul Praino as its VP of sales. Praino will be responsible for expanding the company’s sales efforts for the Jada System, Alydia Health’s device that is designed to encourage normal contraction of the uterus to rapidly stop excessive bleeding after childbirth. “Paul is an experienced commercial sales […]
Orthofix signs exclusive licensing agreement for Igea’s bone and joint stimulation devices
Orthofix (NSDQ:OFIX) today said it entered an exclusive license agreement to commercialize Igea‘s bone, cartilage and soft tissue stimulation products in the U.S. and Canada. Through the agreement, Orthofix has the rights to pursue FDA approvals and commercialization of Italy-based Igea’s platform of orthopedic products. Orthofix will market the products, which will expand its bone […]
BD names Elizabeth McCombs as chief technology officer
BD today said it has appointed Elizabeth McCombs as executive VP and chief technology officer, effective April 26. McCombs succeeds John DeFord and will be responsible for driving the company’s category innovation strategy and leading research and development activities. “Beth has been an influential leader since joining BD, leading R&D for the medical segment to […]
Integra Lifesciences ticks up before hours on Street-beating Q1 results
Integra LifeSciences (NSDQ:IART) today posted first-quarter results that beat the consensus on Wall Street. The company reported profits of $45.4 million, or 53¢ per share, on sales of $360.1 million for the three months ended March 31, for a bottom-line gain of 394.5% on sales growth of 1.62% compared with Q1 2020. Adjusted to exclude one-time […]
AtriCure beats the Street in Q1 results
AtriCure (NASDAQ:ATRC) posted first-quarter results today that beat the consensus forecast on Wall Street. The Mason, Ohio-based company reported losses of -$16.9 million, or -38¢ per share, on sales of $59.3 million for the three months ended March 31, for a sales growth of 11.37% compared with Q1 2020. Adjusted to exclude one-time items, earnings per […]
Accuray names chief medical, technology officer
Accuray (NSDQ:ARAY) today said it has appointed Dr. Jean-Philippe Pignol as its chief medical and technology officer, effective April 15. Pignol will lead the company’s scientific and clinical research activities, develop strategic collaborations, evaluate new technologies and serve as the representative with important industry partners. “We’re thrilled to welcome Dr. Pignol, whose rich and unique […]
DJO acquires MedShape and its ortho materials tech
Colfax Corp.’s DJO today said it has acquired MedShape for an undisclosed amount. The acquisition expands DJO’s foot and ankle business as MedShape develops a superelastic nickel-titanium shape memory alloy, as well as shape memory polymer technologies. Other technologies in the deal include devices for fracture fixation, joint fusion and soft tissue injury repair that […]
This device stops aorta blood flow to save lives
Stopping internal bleeding from torso trauma has its technological challenges. Asha Parekh, co-founder and CEO of Front Line Medical Technologies, has developed a small, quick and easy device that could solve the problem. Front Line Medical Technologies (London, Ontario) is an early-stage medical device company that is developing a way to stop internal bleeding with […]
Ambu nabs Health Canada clearance for single-use cystoscope
Ambu (CPH:AMBU-B) today said it received Health Canada clearance for its aScope 4 Cysto single-use cystoscope. The cystoscope is a flexible, single-use endoscope that is designed to eliminate significant capital, repair and cleaning costs with a patient-ready instrument for every procedure, according to Ambu. The device is used for diagnosing, managing and treating lower urinary disorders […]
Orthofix wins FDA clearance for 3D printed TLIF spacer system
Orthofix (NSDQ:OFIX) today said it received FDA 510(k) clearance for its Forza Ti TLIF spacer system. The Forza Ti spacer is designed to optimize transforaminal lumbar interbody fusion (TLIF) procedures, according to the company. It has a titanium 3D-printed interbody with porosity and surface that allows bones to grow into and through the spacer. Interbody […]
atHeart Medical launches atrial septal defect occluder trial
AtHeart Medical is initiating a U.S. investigational device exemption trial for its atrial septal defects (ASD) occluder. The reSept ASD Occluder is an occluder with a metal-free, bioresorbable frame. The implant is designed to overcome the limitations of occluders by reducing the risk of complications associated with the long-term presence of metal in the heart […]